Valuation Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 04:00:02 2026-06-18 pm EDT			5-day change	1st Jan Change
185.00 ^USD	+1.46%		-1.34%	-7.26%

Jun. 18	Charles River Laboratories International, Inc. and Eli Lilly and Company Enter Collaboration to Optimize Ai/Ml Platform Through Nonclinical Testing Expertise	CI
Jun. 18	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	8,911	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	-11.1%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	10,723	10,376	9,995
Change	-	-36.28%	7.39%	-20.91%	3.29%	-10.23%	-3.24%	-3.67%
P/E	49.4x	23.1x	25.9x	931x	-70x	30.2x	20.2x	18.6x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	2.7x	2.46x	2.23x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0.4x	2.15x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	2.31x	2.27x	2.17x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	2.78x	2.64x	2.43x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	10.9x	9.9x	8.96x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	13.2x	11.7x	10.5x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	30.8x	26.4x	41.7x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	3.24%	3.79%	2.4%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	6.135	9.169	9.961
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,853	3,924	4,105
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	986.3	1,048	1,115
EBIT ¹	742.1	834	838.8	805.9	793.9	813.1	883.6	950.9
Net income ¹	391	486.2	474.6	10.3	-144.3	285.1	417.3	447
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	1,812	1,465	1,084
Reference price ²	375.34	218.92	238.84	186.16	203.66	185.00	185.00	185.00
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	48,168	-	-
Announcement Date	2/16/22	2/22/23	2/14/24	2/19/25	2/18/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	30.16x	2.78x	10.87x	-.--%	8.91B
LONZA GROUP AG	30.11x	5.34x	16.53x	1.09%	43.13B
REVOLUTION MEDICINES, INC.	-20.5x	304.3x	-18.74x	-.--%	34.65B
BEONE MEDICINES AG	40.3x	4.01x	25.68x	-.--%	30.03B
IQVIA HOLDINGS INC.	20.41x	2.41x	10.42x	-.--%	28B
CELLTRION, INC.	28.67x	7.42x	19.09x	0.44%	24.45B
MEDPACE HOLDINGS, INC.	27x	4.32x	19.66x	-.--%	13.14B
EUROFINS SCIENTIFIC SE	21.71x	1.89x	8.32x	1.23%	12.53B
IONIS PHARMACEUTICALS, INC.	-20.52x	13.52x	-20.12x	-.--%	12.25B
Average	17.48x	38.44x	7.97x	0.31%	23.01B
Weighted average by Cap.	17.94x	55.12x	8.72x	0.35%